Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:38PM EDT. Market open.
| Previous close | 128.32 |
| Open | 127.48 |
| Bid | 128.56 x 100 |
| Ask | 129.14 x 200 |
| Day's range | 124.98 - 128.90 |
| 52-week range | 62.55 - 142.79 |
| Volume | |
| Avg. volume | 3,862,001 |
| Market cap | 49.4B |
| Beta (5Y monthly) | 1.57 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Investor's Business Daily
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Moderna is on the rise after the Food and Drug Administration delayed a decision on its RSV vaccine. But is MRNA stock, once again, a buy?
- Zacks
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Moderna's (MRNA) RSV vaccine, mRNA-1345's review timeline gets delayed. A decision is now expected by the end of May.
- Simply Wall St.
While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week ago aren't so fortunate
Long term investing can be life changing when you buy and hold the truly great businesses. And we've seen some truly...
© 2024 Yahoo. All rights reserved.